Semicarbazide-sensitive amine oxidase and extracellular matrix deposition by smooth-muscle cells

Cardiovascular Toxicology

Volumn 2, Issue 2, 2002, Pages 141-150

  Langford, Shannon D ^a   Trent, Margaret B ^b   Boor, Paul J ^b,c  

^a NASA JOHNSON SPACE CENTER   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Extracellular matrix (ECM); Semicarbazide sensitive amine oxidase (SSAO); Smooth muscle cells (SMCs)

Indexed keywords

AMINE OXIDASE (COPPER CONTAINING); 2 (3,4 DIMETHOXYPHENYL) 3 FLUOROALLYLAMINE; 2-(3,4-DIMETHOXYPHENYL)-3-FLUOROALLYLAMINE; ALLYL COMPOUND; ALLYLAMINE; COLLAGEN; DRUG DERIVATIVE; ELASTIN; ENZYME INHIBITOR; MDL 72274A; MONOAMINE OXIDASE INHIBITOR; PROPYLAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CARDIOVASCULAR PERFORMANCE; COLLAGEN DEFECT; CONTROLLED STUDY; CYTOARCHITECTURE; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; ENZYME MECHANISM; ENZYME SUBSTRATE; EXTRACELLULAR MATRIX; HEART CELL CULTURE; HEART MUSCLE CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; SMOOTH MUSCLE FIBER; ANIMAL; ANIMAL MODEL; BIOLOGICAL MODEL; CELL CULTURE; CLASSIFICATION; COMPARATIVE STUDY; CYTOLOGY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; HEART MUSCLE; METABOLISM; SPRAGUE DAWLEY RAT; TIME;

ANIMALIA;

ALLYL COMPOUNDS; ALLYLAMINE; AMINE OXIDASE (COPPER-CONTAINING); ANIMALS; CELLS, CULTURED; COLLAGEN; DOSE-RESPONSE RELATIONSHIP, DRUG; ELASTIN; ENZYME INHIBITORS; EXTRACELLULAR MATRIX; MODELS, ANIMAL; MODELS, CARDIOVASCULAR; MONOAMINE OXIDASE INHIBITORS; MYOCARDIUM; MYOCYTES, SMOOTH MUSCLE; PROPYLAMINES; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 0036368582     PISSN: 15307905     EISSN: None     Source Type: Journal    
DOI: 10.1385/CT:2:2:141     Document Type: Article

References (28)

1. Weber, K.T., Sun, Y., Tyagi, S.C., and Cleutjens, J.P.M. (1994). Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms. J. Mol. Cell. Cardiol. 26:279-292.
2. Masutoma, K., Makino, N., Suganao, M., Miyamoto, S., Hata, T., and Yanaga, T. (1999). Extracellular matrix regulation in the development of Syrian cardiomyopathic Bio 14.6 and Bio 53.58 Hamsters. J. Mol. Cell. Cardiol. 31:1607-1615.
3. Conklin, D.J., Langford, S.D., and Boor, P.J. (1998). Contributions of serum and cellular semicarbazide-sensitive amine oxidase to amine metabolism and cardiovascular toxicity. Toxicol. Sci. 46:386-392.
4. Langford, S.D., Trent, M.B., and Boor, P.J. (2001). Cultured rat vascular smooth muscle cells are resistant to methylamine toxicity: No correlation to semicarbazide-sensitive amine oxidase. Cardiovasc. Toxicol. 1:51-60.
5. Langford, S.D., Trent, M.B., Balakumaran, A., and Boor, P.J. (1999). Developmental vasculotoxicity associated with inhibition of semicarbazide-sensitive amine oxidase. Toxicol. Appl. Pharmacol. 155:237-244.
6. Palfreyman, M.G., McDonald, I.A., Bey, P., Danzin, C., Zreika, M., and Cremer, G. (1994). Haloallylamine inhibitors of MAO and SSAO and their therapeutic potential. J. Neural Transm. 41(Suppl.):407-414.
7. Bey, P., Fozard, J., Lacosta, J.M., McDonald, I.A., Zreika, M., and Palfreyman, M.G. (1984). (E)-2-(3,4-Dimethoxy)-3-fluoroallylamine: a selective, enzyme activated inhibitor of type B monoamine oxidase. J. Med. Chem. 27:9-10.
8. Lyles, G.A. and Fitzpatrick, C.M.S. (1985). An allylamine derivative (MDL-72145) with potent irreversible inhibitory actions on rat aorta semicarbazide-sensitive amine oxidase. J. Pharm. Pharmacol. 37:329-335.
9. Boor, P.J., Moslen, M.T., and Reynolds, E.S. (1979). Allylamine cardiotoxicity: I. Sequence of pathologic events. Toxicol. Appl. Pharmacol. 50:581-592.
10. Lyles, G.A. and Teneja, D.T. (1987). Effects of amine oxidase inhibitors upon tryptamine metabolism and tryptamine-induced contractions of rat aorta. Br. J. Pharmacol. 90:16P.
11. Jones, P.A., Scott-Burden, T., and Gevers, W. (1979). Glycoprotein, elastin, and collagen secretion by rat smooth muscle cells. Proc. Natl. Acad. Sci. USA 76(1):353-357.
12. Oakes, B.W., Batty, A.C., Handley, C.J., and Sandberg, L.B. (1982). The synthesis of elastin, collagen, and glycosaminoglycans by high density primary cultures of neonatal rat aortic smooth muscle. An ultrastructural and biochemical study. Eur. J. Cell. Biol. 27:34-46.
13. DeClerck, Y.A. and Jones, P.A. (1980). The effects of ascorbic acid on the nature and production of collagen and elastin by rat smooth-muscle cells. Biochem. J. 186:217-225.
14. McMahon, M.P., Faris, B., Wolfe, B.L., et al. (1985). Aging effects on the elastin composition in the extracellular matrix of cultured rat aortic smooth muscle cells. In Vitro Cell. Dev. Biol. 21:674-680.
15. Lewinsohn, R., Bohm, K.H., Glover, V., and Sandler, M.A. (1978). A benzylamine oxidase distinct from monoamine oxidase B - wide spread distribution in man and rat. Pharmacology 27:1857-1863.
16. Bradford, M.M. (1976). A rapid and sensitive method for the quantitation of micrograms of protein using the principle of protein-dye binding. Anal. Biochem. 72:248-254.
17. Hoffman, L., Blumenfeld, O.O., Mondshine, R.B., and Park, S.S. (1972). Effect of DL-penicillamine on fibrous protein of rat lung. J. Appl. Physiol. 33:42-46.
18. Kacem, K., Selaz, J., and Aubineau, P. (1996). Differential processes of vascular smooth muscle cell differentiation within elastic and muscular arteries of rat and rabbits: an immunofluorecence study of desmin and vimentin distribution. Histochem. J. 28:53-61.
19. Gabbiani, G., Schmid, E., Winter, S., et al. (1981). Smooth muscle cells differ from other muscle cells: predominance of vimentin filaments and a specific α-type actin. Proc. Natl. Acad. Sci. USA 78(1):298-302.
20. Frank, E.D. and Warren, L. (1981). Aortic smooth muscle cells contain vimentin instead of desmin. Proc. Natl. Acad. Sci. USA 78(5):3020-3024.
21. Boor, P.J. and Ferrans, V.J. (1985). Ultrastructural alterations in allylamine cardiovascular toxicity: late myocardial and vascular lesions. Am. J. Pathol. 121:39-54.
22. Stout, L.C., Boor, P.J., and Horton, E. (1988). Myofibroblastic proliferation on mitral valve chordae tendineae. A distinctive lesion associated with alcoholic liver disease. Hum. Pathol. 19:720-725.
23. Adam, D., Boor, P.J., Callingham, B., et al. (2000). Physiological and pathological implications of semicarbazide-sensitive amine oxidase (SSAO) also known as vascular adhesion molecule (VAP-1). 6th Internet World Congress for Biomedical Sciences (INABIS 2000), No. 21.
24. Salmi, M. and Jalkanen, S. (1992). A 90-kilodalton endothelial cell molecule mediating lymphocyte binding in humans. Science 257:1407-1409.
25. Jaakkola, K., Kaunismaki, K., Tohka, S., et al.. (1999). Human vascular adhesion protein-1 in smooth muscle cells. Am. J. Pathol. 155:1953-1965.
26. Boor, P.J., Trent, M.B., and Langford, S.D. (2000). A model of aortic aneurysm: involvement of tissue amine oxidase and aging. Abstracts of American Federation for Aging Research Meeting, p. 26.
27. Boomsma, F., Derkx, F.H.M., van den Meiracker, A.H., Man in t' Veld, A.J., and Schalekamp, M.A.D.H. (1995). Plasma semicarbazide-sensitve amine oxidase activity is elevated in diabetes mellitus and correlates with glycosylated haemoglobin. Clin. Sci. 88:675-679.
28. Hayes, B.E. and Clarke, D.E. (1990). Semicarbazide-sensitive amine oxidase activity in streptozotocin diabetic rats. Res. Commun. Chem. Pathol. Pharmacol. 69:71-83.